Prevalence, clinical manifestations, etiology, and treatment of depression in Parkinson's disease

被引:198
作者
Slaughter, JR [1 ]
Slaughter, KA [1 ]
Nichols, D [1 ]
Holmes, SE [1 ]
Martens, RP [1 ]
机构
[1] Univ Missouri, Dept Psychiat & Neurol, Sch Med, Columbia, MO 65212 USA
关键词
D O I
10.1176/appi.neuropsych.13.2.187
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
To determine the extent to which depression complicates Parkinson's disease (PD), the authors analyzed the literature on depression in PD in order to report on its prevalence, clinical manifestations, and treatment. By means of MEDLINE literature searches, the analysis focused on 45 PD depression studies conducted from 1922 through 1998. The results indicate that the prevalence of depression is 31% for all PD patients. The clinical manifestations of PD depression include apathy, psychomotor retardation, memory impairment, pessimism, irrationality, and suicidal ideation without suicidal behavior. PD depression is effectively treated with a variety of antidepressants, most commonly at present the selective serotonin reuptake inhibitors. Anecdotal evidence supports the use of sertraline to treat PD depression.
引用
收藏
页码:187 / 196
页数:10
相关论文
共 97 条
[11]   ACCURACY OF SELF-REPORTED DISABILITY IN PATIENTS WITH PARKINSONISM [J].
BROWN, RG ;
MACCARTHY, B ;
JAHANSHAHI, M ;
MARSDEN, CD .
ARCHIVES OF NEUROLOGY, 1989, 46 (09) :955-959
[12]   RESPONSE CHOICE IN PARKINSONS-DISEASE - THE EFFECTS OF UNCERTAINTY AND STIMULUS-RESPONSE COMPATIBILITY [J].
BROWN, RG ;
JAHANSHAHI, M ;
MARSDEN, D .
BRAIN, 1993, 116 :869-885
[13]   PSYCHIATRIC MORBIDITY IN PATIENTS WITH PARKINSONS-DISEASE [J].
BROWN, RG ;
MACCARTHY, B .
PSYCHOLOGICAL MEDICINE, 1990, 20 (01) :77-87
[14]   MOOD CHANGES ASSOCIATED WITH END-OF-DOSE DETERIORATION IN PARKINSONS-DISEASE - A CONTROLLED-STUDY [J].
CANTELLO, R ;
GILLI, M ;
RICCIO, A ;
BERGAMASCO, B .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1986, 49 (10) :1182-1190
[15]  
CELESIA GG, 1972, DIS NERV SYST, V33, P577
[17]   STUDIES OF DEMENTIA, DEPRESSION, ELECTROPHYSIOLOGY AND CEREBROSPINAL-FLUID MONOAMINE METABOLITES IN PATIENTS WITH PARKINSONS-DISEASE [J].
CHIA, LG ;
CHENG, LJ ;
CHUO, LJ ;
CHENG, FC ;
CU, JS .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1995, 133 (1-2) :73-78
[18]  
COFFEY CE, 1994, TXB GERIATRIC NEUROP, P434
[19]  
Cole SA, 1996, J NEUROPSYCH CLIN N, V8, P20
[20]  
CUMMINGS JL, 1992, AM J PSYCHIAT, V149, P443